Bedrijfsoverzicht
Natural Alternatives International, Inc. is a specialized entity focused on the formulation, manufacturing, and marketing of nutritional supplements, serving both domestic and international markets through two distinct operational segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing. The corporation operates within the Consumer Defensive sector, specifically categorized under the Packaged Foods industry, a classification that generally implies a business model with potentially resilient demand patterns relative to discretionary spending, although the specific nature of nutritional supplements may vary from staple goods. The company maintains a market capitalization of $17.50M and employs a workforce of 293 individuals to support its operations. This combination of a relatively small market cap and annual revenue of $135.16M indicates that NAII functions as a micro-cap enterprise with a niche presence, rather than a dominant market leader, which often translates to higher volatility and limited analyst coverage compared to larger peers in the consumer staples space.
Financiële gezondheid
The company reported a total revenue of $135.16M over the trailing twelve months, yet this top-line activity resulted in a net income loss of $-12,246,000, revealing a significant disconnect where operating costs and expenses substantially exceeded gross profits. Despite the negative net income, the firm generated an EBITDA of $424,000, suggesting that while accounting for non-cash items or significant interest expenses, the core operational cash generation before these factors remains positive. This divergence between revenue and net income highlights a cost structure burdened by substantial interest obligations or other non-operating charges that erode profitability despite sales volume. In terms of liquidity and flexibility, the company produced free cash flow of $108,500, a positive figure that provides a buffer for ongoing operations and potential capital expenditures even in the absence of net income. The balance sheet shows a cash position of $3.75M standing against total debt of $61.71M, illustrating a highly leveraged financial posture where liabilities significantly outweigh liquid assets. This leverage is further quantified by a debt-to-equity ratio of 92.04, indicating that the company relies heavily on borrowed capital relative to shareholder equity, which increases financial risk during periods of rising interest rates or economic contraction. Solvency in the short term is supported by a current ratio of 1.87, which suggests the company holds sufficient current assets to cover its current liabilities, providing a safety margin against immediate liquidity crises. Finally, the return on equity stands at -16.8% and the return on assets is -1.7%, metrics that collectively indicate that management has been ineffective at generating positive returns for shareholders or utilizing the company's asset base efficiently during this reporting period.
Waarderingsbeoordeling
Valuation multiples for Natural Alternatives International, Inc. present a complex picture due to its profitability challenges, as the trailing P/E ratio and forward P/E ratio are both listed as N/A, implying that the absence of positive earnings precludes the use of standard earnings-based valuation methods. Consequently, the market values the company primarily based on its book value, reflected in a price-to-book ratio of 0.25, which indicates that the stock trades at a significant discount to its net asset value, often a signal of deep value or, conversely, concerns regarding asset quality and future earnings potential. Alternative valuation metrics such as the price-to-sales ratio of 0.13 and the EV/EBITDA of 176.80 suggest that the market prices the company at a fraction of its sales revenue, while the extremely high EV/EBITDA multiple reflects the difficulty in valuing a company with minimal EBITDA relative to its enterprise value. Regarding trading range, the stock has fluctuated between a 52-week low of $2.33 and a 52-week high of $4.96, and without a specific current price provided in the facts, the valuation context must be interpreted through these historical bounds alone. The stock exhibits a beta of 0.39, a figure well below 1.0, which signifies that the share price is significantly less volatile than the broader market and tends to move with less intensity than the S&P 500, offering a degree of stability often sought by defensive investors, though this low volatility can sometimes correlate with lower liquidity or lower interest in the stock.
Growth & Income
The company demonstrated a revenue growth rate of 2.1% year-over-year, while earnings growth is listed as N/A due to the negative net income, indicating that the firm is currently in a phase of revenue expansion that has not yet translated into profitable earnings. Since the company does not pay dividends, the dividend yield and payout ratio are both N/A, meaning that any cash flow generated is retained within the business to fund operations or pay down the substantial debt load rather than being distributed to shareholders. The lack of a dividend payout ratio of 0.0% confirms that the company is not in a stage of paying out earnings, likely due to the negative net income and the need to preserve cash for solvency given the high debt levels. Overall, the growth and income profile is characterized by modest top-line expansion in a defensive sector but is currently constrained by profitability issues and a reliance on retained earnings rather than income generation or dividend distributions.